PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Hydro-methanolic extracts of P. maculosa were assessed for cardioprotective properties, evaluating effects on cardiac TNF-α, Nrf2, CBR1, and various oxidative stress markers [PMID:38952773]
Ethanol extracts exhibited anti-virulence potential, with a maximal inhibitory effect of approximately 50% against biofilm formation at 50 μg/mL [PMID:32326481]
Isolated compounds (1-5, 7, 9-11) did not reduce cell viability to less than 80% of the control [PMID:32433929]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 36746370 (2023) — HPLC-DAD-MS3 fingerprints of phenolics of selected Polygonum taxa and their chemometric analysis. · Phytochemistry
- 2.PMID: 38952773 (2024) — The cardioprotective properties of Persicaria maculosa and Citrus sinensis extracts against doxorubicin-induced cardiotoxicity in mice. · Avicenna journal of phytomedicine
- 3.PMID: 32326481 (2020) — Anti-Virulence Potential and In Vivo Toxicity of Persicaria maculosa and Bistorta officinalis Extracts. · Molecules (Basel, Switzerland)
- 4.PMID: 32635342 (2020) — Phenolic Fingerprinting, Antioxidant, and Deterrent Potentials of Persicaria maculosa Extracts. · Molecules (Basel, Switzerland)
- 5.PMID: 32433929 (2020)